Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

Fig. 3

Unadjusted cumulative probabilities of death and discharge from ICU admission. A between ACEi/ARB and non-ACEi/ARB groups; B between ACEI, ARB and non-ACEI/ARB groups. Results are not adjusted for baseline characteristics. ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker, ICU intensive care unit

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us